5-Formamidoimidazole-4-carboxamide ribotide
![]() | |
| Names | |
|---|---|
| IUPAC name (1R)-1,4-Anhydro-1-(4-carbamoyl-5-formamido-1H-imidazol-1-yl)-D-ribitol 5-(dihydrogen phosphate) | |
| Systematic IUPAC name [(2R,3S,4R,5R)-5-(4-Carbamoyl-5-formamido-1H-imidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate | |
| Other names 5-Formamidoimidazole-4-carboxamide ribonucleotide, FAICAR | |
| Identifiers | |
3D model (JSmol) | |
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| MeSH | 5-formamidoimidazole-4-carboxamide+ribotide |
PubChem CID | |
CompTox Dashboard (EPA) | |
| |
| |
| Properties | |
| C10H15N4O9P | |
| Molar mass | 366.223 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references | |
5-Formamidoimidazole-4-carboxamide ribotide (or FAICAR) is an intermediate in the formation of purines. It is formed by the enzyme AICAR transformylase from AICAR and 10-formyltetrahydrofolate.[1]
References
- ^ USA.gov (2005-06-24). "FAICAR C10H15N4O9P". PubChem. National Center for Biotechnology Information. Retrieved 2022-07-09.
